Based on the OI percentage, 60 stocks were on the short-covering list. These included Alkem Laboratories, IndusInd Bank, United Breweries, Dr Lal PathLabs and Aarti Industries.

Trade setup for Thursday: Top 15 things to know before the opening bell

Motilal Oswal recommended Neutral rating on Alkem Laboratories with a target price of Rs 3470 in its research report dated May 20, 2023.

Neutral Alkem Laboratories; target of Rs 3470: Motilal Oswal

Based on the OI percentage, 50 stocks, including Alkem Laboratories, Intellect Design Arena, InterGlobe Aviation, L&T Finance Holdings and Balrampur Chini Mills saw long unwinding.

Trade setup for Wednesday: Top 15 things to know before the opening bell

Alkem Laboratories posted revenue from operations for the fiscal fourth quarter at Rs 2902.60 crore, up 16.9 per cent from Rs 2483.86 crore in the fourth quarter of FY22.

Alkem Laboratories Q4FY23 Results: Profit tumbles 34% to Rs 71 crore, revenue up 16.9% on-year | The Financial Express

Based on the OI percentage, 66 stocks, including Balrampur Chini Mills, REC, Alkem Laboratories, Ashok Leyland, and Jindal Steel & Power saw a short build-up.

Trade setup for today: Top 15 things to know before the opening bell

​​In the pharmaceutical sector, fewer incidents of regulatory breaches and attractive valuations drove fund managers to add stocks such as Alkem Laboratories, Ajanta Pharma, and Dr Reddys Laboratories.

Beaten-down realty, pharma top mutual fund buys in April

Based on the OI percentage, 77 stocks, including Alkem Laboratories, Vedanta, GNFC, Bharat Forge, and Balrampur Chini Mills saw a short build-up.

Based on the OI percentage, 79 stocks including Hindustan Aeronautics, Vedanta, Voltas, Alkem Laboratories, and Vodafone Idea, saw a short build-up.

Trade setup for Friday: Top 15 things to know before the opening bell

Stocks to watch out for today: Bharat Forge, Adani Transmission, Sanofi India, Alkem Laboratories, Infosys, RVNL and more

Stocks in news: Adani Transmission, Infosys, Rail Vikas Nigam, Bharat Forge and more

Bharat Forge: The ‘Investment Committee - Defence Business’ of the company at its meeting has approved the transfer of the company’s stake in Aeron Systems Private Limited (Aeron) to Kalyani Strategic Systems Limited, a wholly-owned subsidiary of

Bharat Forge, Alkem Laboratories, Kanoria Chemicals in focus

✨Crisil, Hero Motocorp और Alkem Laboratories समेत कौनसे शेयर रहेंगे फोकस में?

किन कंपनियों के आएंगे Q3 नतीजे?✅

जानिए #stocksinnews में...
 
#stockmarket  #stocksinfocus  #zeebusiness 

📺 LIVE - bit.ly/3YYlZcq




About Zee Business
--------------------------
 
Zee Business is India's Number 1 Hindi business news channel. It's your channel for profit and wealth. Watch Live coverage of Indian markets - Sensex & Nifty, also for expert insights and advise from our team of experts.
 
--------------------------------------------------------------
 
You can also visit us at:
https://goo.gl/sXWpTF
 
Like us on Facebook:
https://goo.gl/OMJgrn
 
Follow us on Twitter:
https://goo.gl/OjOzpB
 
Subscribe to our other network channels:
Zee News: https://goo.gl/XBvkjZ

Follow us on Google News for latest updates

Zee News:- https://bit.ly/2Ac5G60
Zee Business:- https://bit.ly/36vI2xa
DNA India:- https://bit.ly/2ZDuLRY
WION: https://bit.ly/3gnDb5J
Zee News Apps : https://bit.ly/ZeeNewsApps

STOCKS IN NEWS : Crisil, Hero Motocorp and Alkem Laboratories & Which other stocks will be in focus?

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Alkem Laboratories Limited is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.